Brief: Cytomed Therapeutics Ltd Files For Mixed Shelf Of Up To $50 Million
13/06/2025 21:24
June 13 (Reuters) - CytoMed Therapeutics Ltd F98.F: CYTOMED THERAPEUTICS LTD FILES FOR MIXED SHELF OF UP TO $50 MILLION – SEC FILING Further company coverage: F98.F ((Reuters.Briefs@thomsonreuters.com;))
Recent news on CytoMed Therapeutics
See all newsBrief: Cytomed Therapeutics Limited Announces Receipt Of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Brief: Cytomed Therapeutics Refutes "Misleading" Claims & Reaffirms Clinical Progress
Brief: Cytomed Therapeutics Completes Acquisition Of T Cell Technology From Uk To Treat Cancers In China And India
Brief: CytoMed Therapeutics To Start Dose Level 2 In Angelica Trial Q3 2025
Brief: Cytomed Therapeutics Ltd Files For Mixed Shelf Of Up To $50 Million